Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 03-Jun-24 5:06 PM View:  | Charles River Laboratories ... (CRL) | 31-May-24 | Grant | 648 | -- | -- | 8% 7.68K to 8.33K | |
| 29-May-24 5:51 PM View: | Charles River Laboratories ... (CRL) | 29-May-24 | Payment of Exercise | 36 | $214.51 | $7,722.36 | (< 1%) 7.71K to 7.68K | |
| 29-May-24 5:34 PM View: | Charles River Laboratories ... (CRL) | 28-May-24 | Payment of Exercise | 24 | $217.21 | $5,213.04 | (< 1%) 7.74K to 7.71K | |
| 29-May-24 5:34 PM View: | Charles River Laboratories ... (CRL) | 27-May-24 | Payment of Exercise | 37 | $217.21 | $8,036.77 | (< 1%) 7.78K to 7.74K | |
| 29-May-24 5:34 PM View: | Charles River Laboratories ... (CRL) | 26-May-24 | Payment of Exercise | 50 | $217.21 | $10,860.50 | (< 1%) 7.83K to 7.78K | |
| 11-Mar-24 4:42 PM View: | Charles River Laboratories ... (CRL) | 08-Mar-24 | Private Sale | 808 | $267.52 | $216,156.00 | (10%) 7.83K to 7.02K | |
| 05-Mar-24 4:54 PM View: | Charles River Laboratories ... (CRL) | 04-Mar-24 | Private Sale | 2,750 | $261.05 | $717,890.00 | (26%) 10.58K to 7.83K | |
| 31-Jan-24 5:31 PM View: | Charles River Laboratories ... (CRL) | 29-Jan-24 | Grant | 968 | -- | -- | 10% 9.94K to 10.91K | |
| 31-Jan-24 5:31 PM View: | Charles River Laboratories ... (CRL) | 29-Jan-24 | Payment of Exercise | 326 | $220.28 | $71,811.30 | (3%) 10.91K to 10.58K | |
| 14-Aug-23 4:15 PM View: | Charles River Laboratories ... (CRL) | 10-Aug-23 | Option Exercise | 1,471 | $144.67 | $212,810.00 | 15% 9.94K to 11.41K | (9%) |
| 14-Aug-23 4:15 PM View: | Charles River Laboratories ... (CRL) | 10-Aug-23 | Private Option Sale | 1,471 | $216.54 | $318,530.00 | (13%) 11.41K to 9.94K | |
| 02-Jun-23 3:31 PM View: | Charles River Laboratories ... (CRL) | 01-Jun-23 | Grant | 1,528 | -- | -- | 18% 8.41K to 9.94K | |
| 31-May-23 4:17 PM View: | Charles River Laboratories ... (CRL) | 29-May-23 | Payment of Exercise | 36 | $194.12 | $6,988.32 | (< 1%) 8.45K to 8.41K | |
| 31-May-23 4:17 PM View: | Charles River Laboratories ... (CRL) | 28-May-23 | Payment of Exercise | 24 | $194.12 | $4,658.88 | (< 1%) 8.47K to 8.45K | |
| 31-May-23 4:17 PM View: | Charles River Laboratories ... (CRL) | 27-May-23 | Payment of Exercise | 36 | $194.12 | $6,988.32 | (< 1%) 8.51K to 8.47K | |
| 31-May-23 4:17 PM View: | Charles River Laboratories ... (CRL) | 26-May-23 | Grant | 670 | -- | -- | 9% 7.84K to 8.51K | |
| 22-Feb-23 4:37 PM View: | Charles River Laboratories ... (CRL) | 22-Feb-23 | Payment of Exercise | 51 | $243.60 | $12,423.60 | (< 1%) 7.89K to 7.84K | |
| 30-Jan-23 4:37 PM View: | Charles River Laboratories ... (CRL) | 27-Jan-23 | Grant | 2,096 | -- | -- | 33% 6.44K to 8.53K | |
| 30-Jan-23 4:37 PM View: | Charles River Laboratories ... (CRL) | 27-Jan-23 | Payment of Exercise | 645 | $244.29 | $157,567.00 | (8%) 8.53K to 7.89K | |
| 17-Nov-22 5:27 PM View: | Charles River Laboratories ... (CRL) | 16-Nov-22 | Option Exercise | 855 | $109.34 | $93,485.70 | 13% 6.44K to 7.29K | |
| 17-Nov-22 5:27 PM View: | Charles River Laboratories ... (CRL) | 16-Nov-22 | Option Sale | 855 | $248.59 | $212,544.00 | (12%) 7.29K to 6.44K | |
| 31-May-22 6:12 PM View: | Charles River Laboratories ... (CRL) | 29-May-22 | Payment of Exercise | 54 | $244.41 | $13,198.10 | (< 1%) 6.49K to 6.44K | |
| 31-May-22 6:12 PM View: | Charles River Laboratories ... (CRL) | 28-May-22 | Payment of Exercise | 37 | $244.41 | $9,043.17 | (< 1%) 6.53K to 6.49K | |
| 31-May-22 6:12 PM View: | Charles River Laboratories ... (CRL) | 27-May-22 | Grant | 491 | -- | -- | 8% 6.04K to 6.53K | |
| 23-Feb-22 10:00 PM View: | Charles River Laboratories ... (CRL) | 23-Feb-22 | Payment of Exercise | 56 | $289.58 | $16,216.50 | (< 1%) 6.09K to 6.04K | |
| 23-Feb-22 10:00 PM View: | Charles River Laboratories ... (CRL) | 22-Feb-22 | Payment of Exercise | 51 | $293.61 | $14,974.10 | (< 1%) 6.14K to 6.09K | |
| 01-Feb-22 5:32 PM View: | Charles River Laboratories ... (CRL) | 28-Jan-22 | Grant | 2,741 | -- | -- | 65% 4.23K to 6.97K | |
| 01-Feb-22 5:32 PM View: | Charles River Laboratories ... (CRL) | 28-Jan-22 | Payment of Exercise | 826 | $312.24 | $257,910.00 | (12%) 6.97K to 6.14K | |
| 07-Jun-21 6:23 PM View: | Charles River Laboratories ... (CRL) | 04-Jun-21 | Option Exercise | 1,527 | $144.95 | $221,339.00 | 36% 4.23K to 5.76K | (9%) |
| 07-Jun-21 6:23 PM View: | Charles River Laboratories ... (CRL) | 04-Jun-21 | Private Option Sale | 1,527 | $335.24 | $511,906.00 | (27%) 5.76K to 4.23K | |
| 04-Jun-21 9:34 AM View: | Charles River Laboratories ... (CRL) | 03-Jun-21 | Option Exercise | 800 | $101.47 | $81,175.00 | 19% 4.23K to 5.03K | |
| 04-Jun-21 9:34 AM View: | Charles River Laboratories ... (CRL) | 03-Jun-21 | Option Sale | 800 | $329.76 | $263,809.00 | (16%) 5.03K to 4.23K | |
| 01-Jun-21 6:01 PM View: | Charles River Laboratories ... (CRL) | 29-May-21 | Payment of Exercise | 54 | $337.99 | $18,251.50 | (1%) 4.28K to 4.23K | |
| 01-Jun-21 6:01 PM View: | Charles River Laboratories ... (CRL) | 28-May-21 | Grant | 325 | -- | -- | 8% 3.96K to 4.28K | |
| 04-May-21 3:59 PM View: | Charles River Laboratories ... (CRL) | 01-May-21 | Payment of Exercise | 93 | $332.45 | $30,917.90 | (2%) 4.05K to 3.96K | |
| 23-Feb-21 11:32 AM View: | Charles River Laboratories ... (CRL) | 23-Feb-21 | Payment of Exercise | 84 | $283.59 | $23,821.60 | (2%) 4.14K to 4.05K | |
| 23-Feb-21 11:32 AM View: | Charles River Laboratories ... (CRL) | 22-Feb-21 | Payment of Exercise | 62 | $289.55 | $17,952.10 | (1%) 4.2K to 4.14K | |
| 23-Feb-21 11:32 AM View: | Charles River Laboratories ... (CRL) | 19-Feb-21 | Private Sale | 410 | $290.99 | $119,305.00 | (9%) 4.61K to 4.2K | |
| 02-Feb-21 11:35 AM View: | Charles River Laboratories ... (CRL) | 29-Jan-21 | Grant | 3,162 | -- | -- | 132% 2.4K to 5.56K | |
| 02-Feb-21 11:35 AM View: | Charles River Laboratories ... (CRL) | 29-Jan-21 | Payment of Exercise | 953 | $260.88 | $248,619.00 | (17%) 5.56K to 4.61K | |
| 10-Aug-20 3:20 PM View: | Charles River Laboratories ... (CRL) | 07-Aug-20 | Option Exercise | 3,441 | $111.41 | $383,353.00 | 143% 2.41K to 5.86K | |
| 10-Aug-20 3:20 PM View: | Charles River Laboratories ... (CRL) | 07-Aug-20 | Option Sale | 3,441 | $216.60 | $745,307.00 | (59%) 5.86K to 2.41K | |
| 10-Aug-20 3:20 PM View: | Charles River Laboratories ... (CRL) | 07-Aug-20 | Sale | 15 | $216.60 | $3,248.94 | (< 1%) 2.41K to 2.4K | |
| 02-Jun-20 2:15 PM View: | Charles River Laboratories ... (CRL) | 29-May-20 | Grant | 484 | -- | -- | 25% 1.93K to 2.41K | |
| 04-May-20 12:27 PM View: | Charles River Laboratories ... (CRL) | 01-May-20 | Payment of Exercise | 62 | $144.67 | $8,969.54 | (3%) 1.99K to 1.93K | |
| 24-Feb-20 12:20 PM View: | Charles River Laboratories ... (CRL) | 23-Feb-20 | Payment of Exercise | 56 | $173.64 | $9,723.84 | (3%) 2.05K to 1.99K | |
| 24-Feb-20 12:20 PM View: | Charles River Laboratories ... (CRL) | 22-Feb-20 | Payment of Exercise | 51 | $173.64 | $8,855.64 | (2%) 2.1K to 2.05K | |
| 01-May-19 1:29 PM View: | Charles River Laboratories ... (CRL) | 01-May-19 | Payment of Exercise | 62 | $140.47 | $8,709.14 | (3%) 2.16K to 2.1K | 0% |
| 26-Feb-19 10:00 PM View: | Charles River Laboratories ... (CRL) | 23-Feb-19 | Payment of Exercise | 56 | $144.67 | $8,101.52 | (3%) 2.22K to 2.16K | |
| 26-Feb-19 10:00 PM View: | Charles River Laboratories ... (CRL) | 22-Feb-19 | Grant | 690 | -- | -- | 45% 1.53K to 2.22K |